Elliptic Laboratories Past Earnings Performance
Past criteria checks 0/6
Elliptic Laboratories's earnings have been declining at an average annual rate of -20.6%, while the Software industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 21.4% per year.
Key information
-20.6%
Earnings growth rate
-17.5%
EPS growth rate
| Software Industry Growth | 52.6% |
| Revenue growth rate | 21.4% |
| Return on equity | -7.9% |
| Net Margin | -28.6% |
| Next Earnings Update | 21 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elliptic Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 87 | -25 | 2 | 0 |
| 31 Mar 24 | 87 | -26 | 2 | 0 |
| 31 Dec 23 | 68 | -38 | 2 | 0 |
| 30 Sep 23 | 69 | -37 | 1 | 0 |
| 30 Jun 23 | 74 | -23 | 1 | 0 |
| 31 Mar 23 | 51 | -34 | 1 | 0 |
| 31 Dec 22 | 52 | -33 | 1 | 0 |
| 30 Sep 22 | 77 | -10 | 1 | 0 |
| 30 Jun 22 | 63 | -18 | 1 | 0 |
| 31 Mar 22 | 58 | -17 | 1 | 0 |
| 31 Dec 21 | 55 | -11 | 1 | 0 |
| 30 Sep 21 | 44 | -5 | 1 | 0 |
| 30 Jun 21 | 34 | -9 | 1 | 0 |
| 31 Mar 21 | 32 | -10 | 1 | 0 |
| 31 Dec 20 | 30 | -13 | 1 | 0 |
| 30 Sep 20 | 23 | -24 | 1 | 0 |
| 30 Jun 20 | 29 | -20 | 1 | 0 |
| 31 Mar 20 | 32 | -19 | 1 | 0 |
| 31 Dec 19 | 38 | -13 | 1 | 0 |
| 31 Dec 18 | 42 | -28 | 2 | 0 |
| 31 Dec 17 | 11 | -34 | 3 | 0 |
Quality Earnings: ELABS is currently unprofitable.
Growing Profit Margin: ELABS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELABS is unprofitable, and losses have increased over the past 5 years at a rate of 20.6% per year.
Accelerating Growth: Unable to compare ELABS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ELABS is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (11.2%).
Return on Equity
High ROE: ELABS has a negative Return on Equity (-7.86%), as it is currently unprofitable.